Mereo BioPharma Group’s (MREO) “Buy” Rating Reiterated at Needham & Company LLC
Needham & Company LLC restated their buy rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Free Report) in a report published on Monday morning,Benzinga reports. Needham & Company LLC currently has a $7.00 price target on the stock. A number of other brokerages have also commented on MREO. Jefferies Financial Group assumed coverage on […]
More Stories
USA Financial Formulas Has $83.99 Million Position in iShares S&P 500 Growth ETF (NYSEARCA:IVW)
USA Financial Formulas reduced its stake in iShares S&P 500 Growth ETF (NYSEARCA:IVW – Free Report) by 1.3% during the...
10,291 Shares in iShares U.S. Treasury Bond ETF (BATS:GOVT) Acquired by Meyer Handelman Co.
Meyer Handelman Co. acquired a new stake in iShares U.S. Treasury Bond ETF (BATS:GOVT – Free Report) in the 4th...
ERn Financial LLC Has $2.21 Million Stock Position in First Trust Cloud Computing ETF (NASDAQ:SKYY)
ERn Financial LLC lessened its holdings in shares of First Trust Cloud Computing ETF (NASDAQ:SKYY – Free Report) by 1.3%...
CACI International (NYSE:CACI) Upgraded by Jefferies Financial Group to “Buy” Rating
CACI International (NYSE:CACI – Get Free Report) was upgraded by equities research analysts at Jefferies Financial Group from a “hold”...
Biglari (NYSE:BH) Upgraded by StockNews.com to “Strong-Buy” Rating
StockNews.com upgraded shares of Biglari (NYSE:BH – Free Report) from a buy rating to a strong-buy rating in a research...
KeyCorp Initiates Coverage on Commvault Systems (NASDAQ:CVLT)
Equities researchers at KeyCorp started coverage on shares of Commvault Systems (NASDAQ:CVLT – Get Free Report) in a report released...